Varla-Leftherioti M, Keramitsoglou T, Parapanissiou E, Kurpisz M, Kontopoulou-Antonopoulou V, Tsekoura C, Kamieniczna M, Novokowska B, Paparistidis N, Vrani V, Daniilidis M, Spyropoulou-Vlachou M
Immunobiology Department, Helena Venizelou Maternity Hospital, Athens, Greece.
Tissue Antigens. 2010 Jun;75(6):668-72. doi: 10.1111/j.1399-0039.2010.01451.x. Epub 2010 Mar 4.
This aim of the study was to investigate whether human leukocyte antigen (HLA)-DQA10505 sharing or the maternal killer immunoglobulin-like receptor (KIR) repertoire is associated with recurrent spontaneous abortion (RSA) or repeated implantation failure (RIF). The study included 224 couples with RSA, 61 couples with RIF, 182 fertile couples, and 10 couples with successful in vitro fertilization and embryo transfer (IVF)/ET at first cycle. HLA-DQA10505 typing using polymerase chain reaction-sequence-specific oligonucleotide (PCR-SSO) was performed in 185 RSA (117 with alloimmune abnormalities and 68 of autoimmune etiology), 61 RIF and 182 control couples, and KIR genotyping using polymerase chain reaction-sequence-specific primer (PCR-SSP) in 167 RSA and 55 RIF cases as well as 46 RSA and 10 IVF controls. No differences in DQA10505 sharing were found between patients and controls. In RSA and RIF women, the ratio of inhibitory to activating KIRs was slightly lower (1.53 and 1.85 vs 2.03 in controls). The analysis of maternal inhKIR and fetal HLA-C molecule pairs showed that the 'less inhibiting' combination KIR2DL3-C1 was found in higher percentage in subfertile (mainly RIF) than in fertile couples. In contrast, the percentage of cases possessing the 'strong inhibiting' combination KIR2DL1-C2 was lower in the RSA and RIF groups in comparison with that in the control groups (17.36% vs 23.91 and 16.36% vs 40%, respectively). In women with >or= 6 implantation failures, the KIR2DL1-C2 combination was not found in any of them (P = 0.0014), and the KIR2DL3-C1 combination was not found in the control IVF group. The results oppose the suggestion that increased HLA-DQA10505 sharing predispose to RSA or RIF. The KIR2DL3-C1 combination (or lack of the KIR2DL1-C2 one) is associated with implantation failure.
本研究的目的是调查人类白细胞抗原(HLA)-DQA10505共享或母体杀伤细胞免疫球蛋白样受体(KIR)谱系是否与复发性自然流产(RSA)或反复种植失败(RIF)相关。该研究纳入了224对RSA夫妇、61对RIF夫妇、182对可育夫妇以及10对首次周期体外受精和胚胎移植(IVF)/ET成功的夫妇。对185对RSA夫妇(117对存在同种免疫异常和68对自身免疫病因)、61对RIF夫妇和182对对照夫妇进行了使用聚合酶链反应-序列特异性寡核苷酸(PCR-SSO)的HLA-DQA10505分型,对167例RSA和55例RIF病例以及46例RSA和10例IVF对照进行了使用聚合酶链反应-序列特异性引物(PCR-SSP)的KIR基因分型。患者和对照之间未发现DQA10505共享存在差异。在RSA和RIF女性中,抑制性KIR与激活性KIR的比例略低(分别为1.53和1.85,而对照为2.03)。对母体抑制性KIR和胎儿HLA-C分子对的分析表明,“抑制性较弱”的组合KIR2DL3-C1在不育(主要是RIF)夫妇中的比例高于可育夫妇中的比例。相反,与对照组相比,RSA组和RIF组中具有“强抑制性”组合KIR2DL1-C2的病例百分比更低(分别为17.36%对23.91%以及16.36%对40%)。在有≥6次种植失败的女性中,未发现其中任何一例存在KIR2DL1-C2组合(P = 0.0014),且在对照IVF组中未发现KIR2DL3-C1组合。结果反对HLA-DQA10505共享增加易导致RSA或RIF的观点。KIR2DL3-C1组合(或缺乏KIR2DL1-C2组合)与种植失败相关。